Tofacitinib is prescribed for:
- Rheumatoid arthritis
- Psoriatic arthritis
- Ulcerative colitis
- Ankylosing spondylitis
- Polyarticular juvenile idiopathic arthritis
- Immunology and gastrointestinal conditions
Generic Name: Tofacitinib
Brand Names: Xeljanz
Tofacitinib is a JAK inhibitor for rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and other conditions.
Tofacitinib is prescribed for:
Common side effects:
Serious side effects (boxed warnings):
Tofacitinib is an oral JAK inhibitor that blocks JAK1 and JAK3 signaling pathways.
FDA boxed warnings include increased risks of:
Due to safety concerns, reserved for patients who have failed TNF inhibitors.
For details, see MedlinePlus.
This medication is commonly used to treat or manage the following conditions:
Ulcerative colitis is a chronic inflammatory bowel disease causing ulcers and inflammation in the colon and rectum, driven by immune dysfunction, genetics, and environmental factors, leading to symptoms like diarrhea and abdominal pain.
Lymphoma is a cancer of lymphocytes in the immune system, leading to uncontrolled growth and tumor formation, with various types, causes, and associations to infections and toxins.
A stroke, caused by interrupted brain blood supply from blockage (ischemic) or bleeding (hemorrhagic), is a medical emergency requiring prompt treatment to minimize brain damage.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Tofacitinib? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.